A drug called nimodipine may help protect hearing after tumor surgery
Original title: Prophylactic Nimodipine for Hearing Preservation in Vestibular Schwannoma: A Retrospective Cohort Study.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
Doctors looked back at records of real patients, but it has not been tested in a planned trial.
The short version
People given nimodipine around their surgery kept their hearing and face movement more often.
What was studied. Doctors looked back at patient records from one hospital. The records covered people who had surgery for a tumor called vestibular schwannoma. The surgery aimed to save their hearing. There were 58 patients who did not get nimodipine and 340 who did.
What they found. Patients who got nimodipine were more likely to keep their word understanding. They were also more likely to keep the movement in their face. One hearing test did not show a clear difference. Getting more doses was linked to slightly better results.
What this means, and what it doesn't
What it could mean: Nimodipine might help protect hearing and face movement after this surgery. If you are facing this kind of surgery, you can ask your doctor about it. Your team can tell you if it fits your case.
What it doesn't mean: This does not mean nimodipine is proven to work. Doctors only looked back at old records. They did not run a planned trial. Studies like this can miss other reasons for the results. The authors say more study is needed. This is not a cure for the tumor, and it does not remove the risk of hearing loss.
Source: PubMed, September 28, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.